本报讯（记者 陈强 孙乐琪）昨天上午，首都医科大学宣武医院房山院区暨国家医学中心建设工程建设 动员会在房山区长阳镇举行，标志着该项目正式启动建设。作为本市重点推进的公共服务工程，项目预 计2029年投用，建成后将成为房山区首家三级甲等综合医院，有效提升京西南优质医疗服务能力。 宣武医院现址位于西城区，此次启动的房山院区东片区占地14.3万平方米，总建筑面积19.89万平方米， 规划床位800张。 宣武医院房山院区将打造集智慧、韧性、绿色于一体的"智慧健康生态综合体"。建筑设计独具匠心，南 北两组主体建筑通过放射状交通体系连接中央大厅，形成高效诊疗动线，实现临床、教学、科研、康复 等功能区无缝衔接。这一设计形似神经元共生形态，既凸显了宣武医院在神经科学领域的特色优势，也 为多学科协同发展提供支撑。 智慧医疗是新院区一大亮点。宣武医院房山院区将搭建与宣武医院西城院区同源的数字化诊疗平台，全 面落地远程会诊、人工智能辅助诊断等技术，并引入核磁共振等尖端医疗设备。同时深度融合"互联网 +医疗"模式，患者通过"掌上宣武医院"平台，即可完成在线复诊、医保实时结算、药品配送到家等全流 程服务。 该院区距离地铁房山线广阳城站 ...

Case Overview - The case involves Zhang, who visited an emergency department on November 4, 2020, and disputed the authenticity of the medical records provided by the hospital, claiming potential forgery [1] - Zhang was diagnosed with "acute ischemic stroke, cerebral infarction" on November 5, and sought compensation for medical expenses and emotional damages totaling over 100,000 yuan, but the court dismissed all claims [1] Legal Insights - Medical records are essential for proving the existence of a medical relationship and assessing whether there was a breach in medical practice [2] - The responsibility for maintaining outpatient medical records lies primarily with the patient, while inpatient records are maintained by the medical institution [2] - In litigation, if a patient fails to provide their outpatient records and disputes the authenticity of the hospital's records, it may lead to challenges in proving the case, potentially resulting in a loss [2] Patient Responsibilities - Patients should ensure that medical staff promptly document their medical records and request copies of test results [3] - Proper maintenance and complete provision of medical records during litigation are crucial, as withholding records can lead to adverse outcomes for the patient [3] - In cases where medical records are lost, patients should promptly contact the medical institution for reprints, as many now utilize electronic medical record systems [4]

Group 1 - The core viewpoint of the articles highlights the efforts of Qinghai Province's Medical Insurance Bureau to enhance the accessibility and affordability of healthcare for insured individuals during the 14th Five-Year Plan period [1][2] Group 2 - Qinghai has dynamically adjusted its medical insurance drug list, incorporating 387 national negotiated drugs and competitive drugs into a "dual-channel" guarantee system to improve patient access to medications [1] - An additional 150 types of Tibetan medicinal herbs have been included in the medical insurance payment scope, making a total of 531 types and 3200 items available [1] - The province has included 499 ethnic medical diagnosis and treatment projects in the medical insurance payment scope, achieving an inclusion rate of 88% [1] - 127 surgical procedures have been added to the day surgery settlement range without a threshold, reimbursed according to inpatient policies [1] - Six specific Tibetan and Chinese medicine advantageous disease categories have been included in the day ward medical insurance settlement, with no bed fees charged for hospitalization and nursing fees set at 50% of the standard for tertiary care [1] Group 3 - The province has integrated village health clinics into the medical insurance designated point system, with 4343 out of 4469 clinics now covered, ensuring basic coverage for all administrative villages [2] - A smart regulatory system for medical insurance has been established to enhance early detection and management of illegal activities [2] - The province has optimized the cross-regional medical treatment registration service, allowing for online registration through WeChat mini-programs and the Qinghai Medical Insurance App, effectively eliminating the need for in-person registration [2] - The direct settlement channel has been established to resolve issues related to insured individuals having to pay upfront for services [2]

海南自贸港药品、医疗器械"零关税"政策明确，在博鳌乐城国际医疗旅游先行区内注册登记具有独立法 人资格并经认定的医疗机构、医学教育高等院校、医疗类科研院所，进口政策规定范围内的药品、医疗 器械，可享受免征进口关税、进口环节增值税和消费税。此举可降低医疗机构运营成本，为患者就医减 轻负担。 "这项政策对于我们这些在乐城内注册的医疗机构来说可谓是'锦上添花'，不仅可以减轻患者用药用械 成本，也为我们企业资金周转提供了很大的便利。"海南博鳌超级医院相关负责人冯家龙说。 （来源：工人日报） 为保障"零关税"药械政策实施，海口海关积极研究优化通关流程，深入走访调研了解不同类型企业享惠 政策堵点痛点，研提解决措施，让政策红利精准触及享惠主体。 本报讯（记者赖书闻 通讯员刘一鸣）自2024年12月31日首票业务落地以来，海南自贸港药品、医疗器 械"零关税"政策已平稳运行一周年，政策红利持续释放。据海口海关统计，截至2025年12月31日，海南 累计进口"零关税"药械货值约4.6亿元，减免税款约6200万元。 下一步，海口海关将继续优化监管服务，引导企业用好用足政策，进一步推动"零关税"药械政策红利释 放，助力乐城先行区打造全 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603127 证券简称：昭衍新药 公告编号：2026-001 北京昭衍新药研究中心股份有限公司 关于员工持股计划回购股份注销实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 回购注销原因：北京昭衍新药研究中心股份有限公司（以下简称"公司"）已终止实施2021年及2022年 A股员工持股计划，公司拟注销回购专用账户中的A股共计129,114股。 ● 本次注销股份的有相关情况： ■ 一、本次员工持股计划回购股份注销已履行的决策程序和信息披露情况 （一）2021年A股员工持股计划 公司于2021年9月21日召开第三届董事会第二十九次会议和第三届监事会第二十次会议、于2022年1月19 日召开2022年第一次临时股东大会审议并通过了《关于公司〈2021年A股员工持股计划（草案）及其摘 要的议案》、《关于公司〈2021年A 股员工持股计划管理办法〉的议案》、《关于提请股东大会授权董 事会全权办理员工持股计划相关事宜的议案》，公司实施2021年A ...

Core Viewpoint - The launch of the public hospital reform and high-quality development demonstration project in Xicheng District, Beijing aims to enhance healthcare services through the integration of artificial intelligence and digital technologies in medical practices [1][2] Group 1: Project Overview - The demonstration project will be implemented over three years, focusing on collaborative governance in healthcare, hierarchical diagnosis and treatment, comprehensive reform of public hospitals, and the empowerment of digital technology [1] - The project aims to create replicable and promotable "Xicheng experience" to improve regional healthcare service levels [1] Group 2: Key Tasks and Measures - The implementation plan includes four major tasks and 13 reform measures, emphasizing the sharing of medical resources and the establishment of four centers: medical imaging, testing, pathology, and telemedicine [1] - A "one bed for the entire district" sharing mechanism will be explored, along with pilot programs for unified procurement of drugs, consumables, and equipment to achieve cost reduction and efficiency [1] Group 3: Hospital Development - The project will clarify the functional positioning of district hospitals through "one hospital, one policy" and promote key renovation projects like the revitalization of hospitals and standardized construction of community health service centers [1] - There will be a focus on strengthening specialties in traditional Chinese medicine, rehabilitation, and addressing shortages in geriatrics, pediatrics, psychiatry, and infectious diseases [1] Group 4: Digital Integration - The initiative will deepen the integration of digital technologies, establishing a unified platform for district hospitals, community health, public health, and health information to eliminate information barriers [2] - The project will provide smart health monitoring devices for the elderly and key chronic disease populations, facilitating proactive and continuous health management [2]

高频业务便捷办：支持"异地备案""信息查询"等高频医保业务线上办理，有效分流窗口压力，打破时间 与空间限制，非工作时段也能保障群众顺畅办事，让医保服务更高效省心。 场景延伸多元化：深度融合医院服务场景，未来将拓展"诊间结算""异地结算报错协同""住院查房辅 助""就诊指南查询""专家信息介绍"等多元功能，从医保服务延伸至全流程就医场景，打造一站式智能 服务生态。 作为具备多模态交互能力的人工智能体，"小金灵"能主动精准感知用户意图、理解复杂语义。未来将深 度融合医院"服务知识库"，延伸"诊间结算""异地结算报错协同""住院查房辅助""门诊就诊指南""住院服 务指南""内线电话查询""专家信息介绍"等多元化功能，将服务从医保领域全面拓展至全流程就医场 景，为患者提供一站式、人性化的智能服务，让就医之路更顺畅。 数字化转型浪潮下，人工智能已成为优化医疗服务、破解就医痛点的核心引擎， 近日，江苏省人民医 院（南京医科大学第一附属医院、江苏省妇幼保健院）携手南京医保引入智能服务载体"小金灵"正式入 驻医院。 该院院长刘云表示，"小金灵"入驻是医院智慧医疗服务建设的关键突破，也是AI技术赋能医保服务的重 要实践。医院始 ...

每经编辑｜金冥羽 1月6日，三大指数集体收涨，沪指高开高走，再创十年新高。A股全天成交额达2.83万亿元，较上一个交易日放量2650亿元。全市场超4100只个股上涨， 其中有143只个股涨停，连续两日超百股涨停。从板块来看，商业航天概念持续爆发，脑机接口概念延续强势，截至收盘，沪指涨1.5%，深成指涨1.4%， 创业板指涨0.75%。 盘后，多只商业航天、脑机接口概念牛股齐发公告提示风险。 中国卫星：目前股价已处于历史最高点，公司股价已脱离基本面 中国卫星公告，公司股票自2025年12月3日以来收盘价格累计上涨幅度为156.07%，同期申万军工行业涨幅23.92%，上证A指涨幅5.31%，公司股票短期涨 幅明显高于同期行业及上证指数涨幅，但公司基本面未发生重大变化，存在市场情绪过热、非理性炒作风险，公司股票击鼓传花效应明显，交易风险极 大，存在股价短期快速回落风险。 目前股价已处于历史最高点，公司股价已脱离基本面，敬请广大投资者注意二级市场交易风险，理性决策，审慎投资。 6天4板中国卫通：股价已严重脱离基本面 公司股票"击鼓传花"效应十分明显 中国卫通发布股票交易风险提示性公告称，公司股票短期涨幅高于同期行业 ...

Group 1 - Xinfeng Pharmaceutical is facing criminal charges for unit bribery, which may negatively impact its profits [2] - Aerospace Electronics has seen a stock price increase of 123.23% since November 27, 2025, significantly outpacing the industry and market, indicating potential irrational market behavior [3] - Chipone Technology has completed the acquisition of Zhudian Semiconductor, gaining a 40% stake and control over the company [4] Group 2 - Chaoying Electronics has increased its investment in AI high-end printed circuit board expansion from 1.468 billion to 3.315 billion yuan, with a production capacity target of 166,500 square meters annually [5] - Yihuilong's Brain Machine Star Chain is developing non-invasive brain-machine interface products, but they are still in early stages and not yet registered [6] - Aerospace Changfeng has confirmed it is not engaged in brain-machine interface or commercial aerospace businesses, despite being categorized as such [7] Group 3 - Guosheng Technology's stock will be suspended for trading on January 7, 2026, due to significant price fluctuations, with a cumulative increase of 370.20% since October 31, 2025 [9] - Xiangyu Medical focuses on non-invasive brain-machine interface technology, with no large-scale sales achieved yet, but aims to cover over 1,000 top-tier hospitals by 2026 [10] - Jiamai Packaging's stock has risen by 230.48% from December 17, 2025, leading to a trading suspension for review [11] Group 4 - Zhongtai Co. expects a net profit of 420 million to 480 million yuan for 2025, recovering from a loss of 77.96 million yuan in the previous year [19] - Lier Chemical anticipates a net profit increase of 113.62% to 132.19% for 2025, driven by rising product demand [20] - Pengding Holdings reported a 30.74% increase in consolidated revenue for December 2025, totaling 424.355 million yuan [21] Group 5 - Times New Materials signed a sales contract for wind turbine blades worth approximately 3.32 billion yuan [31] - Jinggong Steel Structure won a bid for a project worth 824 million yuan, representing 4.46% of its latest audited revenue [32] - Robotech's subsidiary ficonTEC signed a significant contract worth approximately 7.7 million euros for automated optical switch packaging [33]

近年来，中国医疗机构床位规模保持增势，每千人床位数已突破7张，远超欧美发达国家。与之相对 应的是公立医院住院率居高不下，上级医院虹吸病人而医疗"强基"缺少需求侧支撑。在此背景下，今 年国家卫健委将以"强基、稳二、控三"为原则，进一步调控三级医院规模和发展速度。 1月5日至6日，全国卫生健康工作会议在北京召开，会议在部署2026年工作时提出，今年全国卫生 健康系统要"倾力推进深化医改政策落实"，推进以公益性为导向的公立医院改革，与此同时，精准实 施医疗卫生强基和康复护理扩容提升工程。 "按照'强基、稳二、控三'原则优化医疗机构功能定位和结构，持续推进医疗卫生强基工程，稳定二级 医院运行并拓展康复护理功能，调控三级医院规模、发展速度，优化结构，全面提升医疗卫生服务公 益性、可及性和能力水平。"会议称。 根据国家卫健委去年12月发布的《2024年我国卫生健康事业发展统计公报》，2024年，公立医院床 位扩张态势有所减缓，但全国床位规模仍整体继续增加，每千人口医疗卫生机构床位数由2023年 2026.01. 06 本文字数：944，阅读时长大约1分钟 作者 | 第一财经 吴斯旻 （注：我们会对线索进行核实。您的隐私将 ...